NCT00994942View on ClinicalTrials.gov

Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted Conditions

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Pain
Interventions
DRUG

morphine sulfate

morphine sulfate 30 mg tablet, morphine sulfate 30 mg (10 mg / 5 mL) oral solution, morphine sulfate injection 10 mg (1 mg / mL)

Trial Locations (1)

78759

CEDRA Clinical Research, Austin

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00994942 - Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted Conditions | Biotech Hunter | Biotech Hunter